Cargando…
Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
Mycobacterium tuberculosis (M. tb), the causative agent of TB, is a recalcitrant pathogen that is rife around the world, latently infecting approximately a quarter of the worldwide population. The asymptomatic status of the dormant bacteria escalates to the transmissible, active form when the host’s...
Autores principales: | Alsayed, Shahinda S. R., Gunosewoyo, Hendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049048/ https://www.ncbi.nlm.nih.gov/pubmed/36982277 http://dx.doi.org/10.3390/ijms24065202 |
Ejemplares similares
-
Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells
por: Alsayed, Shahinda S. R., et al.
Publicado: (2021) -
Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents
por: Alsayed, Shahinda S. R., et al.
Publicado: (2020) -
Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022) -
Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023) -
Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis
por: Kwon, Yong-Soo
Publicado: (2017)